Tamoxifen Citrate

ACTIVE HALF-LIFE 5-7 Days
CLASSIFICATION SERM (Selective Estrogen Receptor Modulator)
DOSAGE 20 mg/day
ACNE None
WATER RETENTION None
HBR Not Present
HEPATOTOXICITY Not Present
AROMATIZATION Not Present
MANUFACTURER Hilma Biocare
LAB TEST Refer to Documentation
WAREHOUSE EU Warehouse 3
SUBSTANCE Tamoxifen Citrate

Unlock the potential of Tamoxifen Citrate, a powerful agent renowned for its dual role as both an estrogen antagonist and agonist in diverse tissues. Originally developed in 1961 by ICI (now AstraZeneca), Tamoxifen has emerged as a cornerstone treatment for breast cancer and is also effective in managing estrogen-related side effects that can arise from anabolic steroid use. Beyond breast cancer, Tamoxifen Citrate is beneficial in treating various cancers such as ovarian, endometrial, prostate, and kidney cancers, along with melanoma and soft tissue sarcomas, specifically in tumors that express estrogen receptors. This Selective Estrogen Receptor Modulator (SERM) is a popular choice among bodybuilders for post-cycle therapy (PCT).

During PCT, Tamoxifen Citrate plays a crucial role in helping athletes restore normal testosterone levels and rejuvenate libido, which may decline due to steroid use.

While generally well-tolerated, common side effects of Tamoxifen Citrate may include headaches, insomnia, nausea, digestive discomfort, fatigue, and leg cramps.

For enhanced results, Tamoxifen Citrate can be effectively stacked with clomiphene during post-cycle therapy.